Advertisement

Topics

Acticor Biotech Announces the Closing of a 1.7 Million Equity Financing Led by Primer Capital

06:30 EST 5 Jan 2018 | Topix

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including stroke and other thrombosis disorders like pulmonary embolism, announces today the closing of an equity financing led by Primer Capital. The financing round includes investments in equity from Primer Capital and historical shareholders - Anaxago, CapDecisif Management - and private investors for 1.7 million and grants from Concours Mondial de l'Innovation for 2.2 million, for a total of 3.9 million.

Original Article: Acticor Biotech Announces the Closing of a 1.7 Million Equity Financing Led by Primer Capital

NEXT ARTICLE

More From BioPortfolio on "Acticor Biotech Announces the Closing of a 1.7 Million Equity Financing Led by Primer Capital"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...